Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1998-07-31
2000-09-19
Kishore, Gollamudi S.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
935 54, A61K 9127
Patent
active
061207993
ABSTRACT:
Angiogenic endothelial cells are selectively targeted with lipid/DNA complexes or cationic liposomes containing a substance which affects the targeted cells by inhibiting or promoting their growth. A site of angiogenesis can be precisely located by administering cationic liposomes containing a detectable label. The complexes may comprise nucleotide constructs which are comprised of promoters which are selectively and exclusively activated in the environment of an angiogenic endothelial cell.
REFERENCES:
patent: 5264618 (1993-11-01), Felgner et al.
patent: 5641755 (1997-06-01), Weichselbaum
patent: 5770581 (1998-06-01), Weichselbaum
patent: 5830880 (1998-11-01), Sedlacek et al.
patent: 5837682 (1998-11-01), Folkman
patent: 5885833 (1999-03-01), Mueller et al.
Teifel et al., "Optimization of Transfection of Human Endothelial Cells," Endothelium, 3:21-35 (1997).
Baluk Peter
McDonald Donald M.
McLean John
Thurston O. Gavin
Bozicevic Karl
Kishore Gollamudi S.
The Regents of the University of California
LandOfFree
Cationic lipid compositions targeting angiogenic endothelial cel does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cationic lipid compositions targeting angiogenic endothelial cel, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cationic lipid compositions targeting angiogenic endothelial cel will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1069644